Eric Sachetta bought $98k of SRTS
director at Sensus Healthcare, Inc.. 31,000 shares at an average of $3.16, traded Aug 20, 2026, filed Aug 24, 2026.
Score components
- +15RoleDirector
- +10Trade size$98k at market
- +6Relative to holdingsHoldings up 22%
- +8Price context39% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- -5Track recordMedian 6-month excess return -32% over 3 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002097345-26-000010, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | POpen-market purchase Common Stock | +24,000 | $3.13 | $75k | 167,613 | Aug 24, 2026 |
| Aug 21, 2026 | POpen-market purchase Common Stock | +7,000 | $3.25 | $23k | 174,613 | Aug 24, 2026 |
Related signals
Other insiders at Sensus Healthcare, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | Sensus Healthcare, Inc. | Eric Sachetta director | $226k 64,841 shares | +28% | |
| 42Moderate | Sensus Healthcare, Inc. | Eric Sachetta director | $67k 20,633 shares | +10% | |
| 44Moderate | Sensus Healthcare, Inc. | Eric Sachetta director | $113k 34,697 shares | +20% | |
| 48Moderate | Sensus Healthcare, Inc. | Joseph C Sardano CHIEF EXECUTIVE OFFICER | $60k 20,000 shares | +2% | |
| 38Weak | SRTSbuy Sensus Healthcare, Inc. | Eric Sachetta director | $5,003 1,500 shares | +1% | |
| 23Weak | SRTSbuy Sensus Healthcare, Inc. | Eric Sachetta director | $7,620 2,000 shares | +1% | |
| 43Moderate | Sensus Healthcare, Inc. | Eric Sachetta director | $28k 7,000 shares | +5% | |
| 30Weak | Sensus Healthcare, Inc. | Eric Sachetta director | $11k 2,500 shares | +2% | |
| 50Moderate | Sensus Healthcare, Inc. | Joseph C Sardano CHIEF EXECUTIVE OFFICER | $101k 25,000 shares | +2% | |
| 35Weak | Sensus Healthcare, Inc. | Michael Sardano PRESIDENT AND GENERAL COUNSEL | $3,800 1,000 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.